510(k) device
Cina
Avicenna.Ai · Radiological Computer-Assisted Triage And Notification Software (QAS, Class II) · First FDA decision Jun 24, 2020, newest Nov 22, 2022Acute ischemic strokeBrain bleeding (hemorrhagic stroke)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Cina"
MAUDE reports
0
Brand "Cina", since 2015
PubMed studies
216
Mentioning "Cina"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cina
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- CINA510(k)
K221716 · Decided Nov 22, 2022 · 162 days after receipt
Device type: Radiological Computer-Assisted Triage And Notification Software (QAS) · Radiology & Imaging
- CINA510(k)
K200855 · Decided Jun 24, 2020 · 85 days after receipt
Device type: Radiological Computer-Assisted Triage And Notification Software (QAS) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cina", any status and sponsor, newest update first.
No registered device study names "Cina".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cina", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QAS
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Cina"[tiab]. The summary above synthesizes these.
- Cina.
Wildes T · Homoeopath Physician · 1892
- Cina-Rheumatism.
Hawley WA · Homoeopath Physician · 1881
- CinA mediates multidrug tolerance in Mycobacterium tuberculosis.
Kreutzfeldt KM, Jansen RS, Hartman TE, et al. · Nat Commun · 2022Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- Synergistic Interaction Effect of Artemisia cina n-hexane Extract and Tagetes lucida Ethyl Acetate Extract on Haemonchus Contortus.
Santiago-Figueroa I, González-Cortazar M, Estrada-Flores JG, et al. · Acta Parasitol · 2024
- Effects of Cina on root-knot disease of mulberry.
Datta SC · Homeopathy · 2006
- CinA is regulated via ComX to modulate genetic transformation and cell viability in Streptococcus mutans.
Mair RW, Senadheera DB, Cvitkovitch DG · FEMS Microbiol Lett · 2012Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Antiparasitic Activity of Silver Nanoparticles Synthesized from Artemisia cina Aqueous Extract Against Haemonchus contortus.
Hernández Guerrero LI, Higuera-Piedrahita RI, de la Cruz-Cruz HA, et al. · Pathogens · 2025Research Support, Non-U.S. Gov't
- Prenatal Nicotine Exposure Raises Male Blood Pressure via FTO-Mediated NOX2/ROS Signaling.
Liu B, Xia L, Li Y, et al. · Hypertension · 2024Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Evaluation of CINA® LVO artificial intelligence software for detection of large vessel occlusion in brain CT angiography.
Mellander H, Hillal A, Ullberg T, et al. · Eur J Radiol Open · 2024
- Understanding Artemisia cina Ethyl Acetate Extract's Anthelmintic Effect on Haemonchus contortus Eggs and L3 Larvae: The Synergism of Peruvin Binary Mixtures.
Arango-De-la Pava LD, González-Cortazar M, Zamilpa A, et al. · Pathogens · 2024Research Support, Non-U.S. Gov't
- Cinnamaldehyde protects SH-SY5Y cells against advanced glycation end-products induced ectopic cell cycle re-entry.
Wu Y, Zhong J, Wang J, et al. · J Pharmacol Sci · 2024
- Bio-guided isolation of a new sesquiterpene from Artemisia cina with anthelmintic activity against Haemonchus contortus L3 infective larvae.
Arango-De la Pava LD, González-Cortázar M, Zamilpa A, et al. · PLoS One · 2024Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code QAS.
- BriefCaseAidoc Medical , Ltd. · 510(k) 2022
- BriefCase-TriageAidoc Medical , Ltd. · 510(k) 2026
- Brainomix 360 Triage StrokeBrainomix Limited · 510(k) 2025
- Annalise Enterprise CTB Triage TraumaAnnalise-Ai Pty , Ltd. · 510(k) 2023
- Rapid ICH (v4.0)Ischemaview, Inc. · 510(k) 2026
- BriefCase-Triage: CARE Multi-Triage CT for PneumothoraxAidoc Medical , Ltd. · 510(k) 2026
- EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)Ever Fortune.Ai, Co., Ltd. · 510(k) 2024
- syngo.CT Brain HemorrhageSiemens Medical Solutions USA, Inc. · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.